Aggregation of a slow-folding mutant of a β-clam protein proceeds through a monomeric nucleus

Biochemistry

Volumn 44, Issue 19, 2005, Pages 7266-7274

  Ignatova, Zoya ^a,b   Gierasch, Lila M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; ESCHERICHIA COLI; FLUORESCENCE; MONOMERS; MUTAGENESIS; NUCLEATION; POLYMERIZATION; X RAY SCATTERING;

ACID-BINDING PROTEINS; FLUORESCENCE SIGNALS; INCLUSION BODIES; PROTEIN AGGREGATION;

PROTEINS;

BINDING PROTEIN; CYSTEINE; PROTEIN BETA CLAM; PROTEIN CRABP 1; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; CELL INCLUSION; CELL NUCLEUS; ESCHERICHIA COLI; FLUORESCENCE; MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN MOTIF; RADIATION SCATTERING;

ALANINE; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ARSENIC; FLUORESCEINS; FLUORESCENT DYES; KINETICS; MICROSCOPY, FLUORESCENCE; ORGANOMETALLIC COMPOUNDS; PROLINE; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, RETINOIC ACID; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

BIVALVIA; ESCHERICHIA COLI;

EID: 18544387148     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi047404e     Document Type: Article

References (33)

1. Stefani, M., and Dobson, C. M. (2003) Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution, J. Mol. Med. 81, 678-699.
2. Wetzel, R. (1996) For protein misassembly, it's the "I" decade, Cell 86, 699-702.
3. Fink, A. L. (1998) Protein aggregation: Folding aggregates, inclusion bodies and amyloid, Folding Des. 3, 9-23.
4. Dobson, C. M. (1999) Protein misfolding, evolution and disease, Trends Biochem. Sci. 24, 329-332.
5. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease, Nat. Med. 10, 10-17.
6. Brujin, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., and Cleveland, D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1, Science 281, 18511-18554.
7. Kosinski-Collins, M. S., and King, J. (2003) In vitro unfolding, refolding and polymerization of human γD crystallin, a protein involved in cataract formation, Protein Sci. 12, 480-490.
8. Speed, M. A., Wang, D. J., and King, J. (1996) Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition, Nat. Biotechnol. 14, 1283-1287.
9. King, J., Haase-Pettingell, C., Robinson, A. S., Speed, M., and Mitraki, A. (1996) Thermolabile folding intermediates: Inclusion bodies precursors and chaperonin substrates, FASEB J. 10, 57-66.
10. Oberg, K., Chrunyk, B. A., Wetzel, R., and Fink, A. L. (1994) Native like secondary structure in interleukin-1β inclusion bodies attenuated total reflectance FTIR, Biochemistry 33, 2628-2634.
11. Przybycien, T. M., Dunn, J. P., Valx, P., and Georgiou, G. (1994) Secondary structure characterization of β-lactamase inclusion bodies, Protein Eng. 7, 131-136.
12. Bennett, M. J., Schlunegger, M. P., and Eisenberg, D. (1994) 3D domain swapping: A mechanism for oligomer assembly, Protein Sci. 4, 2455-2468.
13. Chen, S., Ferrone, F. A., and Wetzel, R. (2002) Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation, Proc. Natl. Acad. Sci. U.S.A. 99, 11884-11889.
14. Harper, J. D., and Lansbury, P. T., Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins, Annu. Rev. Biochem. 66, 385-407.
15. Jarrett, J. T., and Lansbury, P. J. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1050-1058.
16. Lomakin, A., Chung, D. S., Beneder, G. B., Kirschner, D., and Teplow, D. B. (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantification of rate constants, Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129.
17. Ferrone, F. (1999) Analysis of protein aggregation kinetics, Methods Enzymol. 309, 256-274.
18. Hurshman, A. R., White, J. T., Powers, E. T., and Kelly, J. W. (2004) Transthyretin aggregation under partially denaturing conditions is a downhill polymerization, Biochemistry 43, 7365-7381.
19. Lomakin, A., Teplow, D. B., Kirschner, D. A., and Benedek, G. B. (1997). Kinetic theory of fibrillogenesis of amyloid protein, Proc. Natl. Acad. Sci. U.S.A. 94, 7942-7947.
20. Padrick, S. B., and Miranker, A. D. (2002) Islet amyloid: Phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis, Biochemistry 41, 4694-4703.
21. Bitan, G., Kirkitandze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., and Teplow, D. B. (2003) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways, Proc. Natl. Acad. Sci. U.S.A. 100, 330-335.
22. Clark, P. L., and Gierasch, L. M. (1996) Intrinsic tryptophans of CRABP I as probes of structure and folding, Protein Sci. 5, 1108-1117.
23. Clark, P. L., Liu, Z. P., Rizo, J., and Gierasch, L. M. (1997) Cavity formation before stable hydrogen bonding in the folding of a β-clam protein, Nat. Struct. Biol. 4, 883-886.
24. Clark, P. L., Weston, B. F., and Gierasch, L. M. (1998) Probing the folding pathway of a β-clam protein with single-tryptophan constructs, Folding Des. 3, 401-412.
25. Eyles, S. J., and Gierasch, L. M. (2000) Multiple roles of prolyl residues in structure and folding, J. Mol. Biol. 301, 737-747.
26. Ignatova, Z., and Gierasch, L. M. (2004) Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling, Proc. Natl. Acad. Sci. U.S.A. 101, 523-528.
27. Griffin, B. A., Adams, S. R., Jones, J., and Tsien, R. Y. (2000) Fluorescent labeling of recombinant proteins in living cells with FlAsH, Methods Enzymol. 327, 565-578.
28. De Young, L. R., Dill, K. A., and Fink, A. L. (1993) Aggregation and denaturation of apomyoglobin in aqueous urea solutions, Biochemistry 32, 3877-3886.
29. Thakur, A. K., and Wetzel, R. (2002) Mutational analysis of the structural organization of polyglutamine aggregates, Proc. Natl. Acad. Sci. U.S.A. 99, 17014-17019.
30. Rajan, R. S., Illing, M. E., Bence, N. F., and Kopito, R. R. (2001) Specificity in intracellular protein aggregation and inclusion body formation, Proc. Natl. Acad. Sci. U.S.A. 98, 13060-13065.
31. Serpell, L. C., Fraser, P. E., and Sunde, M. (1999) X-ray fiber diffraction of amyloid fibrils, Methods Enzymol. 309, 526-536.
32. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science 297, 353-356.
33. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416, 535-539.